A digital app to help patients with acute myeloid leukemia cope with their diagnosis and treatment.
Multi-Site Randomized Controlled Trial of a Novel Digital Application (DREAMLAND) to Improve Outcomes for Patients with Acute Myeloid Leukemia
['FUNDING_R01'] · MASSACHUSETTS GENERAL HOSPITAL · NIH-10851083
This study is testing a new app called DREAMLAND that helps people with acute myeloid leukemia feel better emotionally and cope with the challenges of chemotherapy, making their hospital experience more supportive and positive.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MASSACHUSETTS GENERAL HOSPITAL (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-10851083 on ClinicalTrials.gov |
What this research studies
This research investigates a new digital application called DREAMLAND designed to improve the quality of life and psychological well-being of patients diagnosed with acute myeloid leukemia (AML). The app offers four modules that provide supportive psychotherapy, psychoeducation, and coping strategies to help patients manage the emotional and physical challenges they face during intensive chemotherapy. By utilizing this app, patients can access resources and support tailored to their needs, especially during the critical period of hospitalization. The goal is to enhance their overall experience and outcomes during treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have recently been diagnosed with acute myeloid leukemia and are beginning intensive chemotherapy.
Not a fit: Patients who are not diagnosed with acute myeloid leukemia or those who are not undergoing intensive chemotherapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the emotional and psychological well-being of patients undergoing treatment for acute myeloid leukemia.
How similar studies have performed: Previous research has shown that digital interventions can effectively support patients with chronic illnesses, suggesting that this approach may also be beneficial for AML patients.
Where this research is happening
BOSTON, UNITED STATES
- MASSACHUSETTS GENERAL HOSPITAL — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: EL-JAWAHRI, AREEJ — MASSACHUSETTS GENERAL HOSPITAL
- Study coordinator: EL-JAWAHRI, AREEJ
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acute Stress Disorders